• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE TAXUS® LIBERTÉ®; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE TAXUS® LIBERTÉ®; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493893612300
Device Problem Occlusion Within Device (1423)
Patient Problems Arrhythmia (1721); Chest Pain (1776); Cardiac Enzyme Elevation (1838); Myocardial Infarction (1969); Thrombosis (2100); Cardiogenic Shock (2262); Sweating (2444)
Event Date 04/21/2014
Event Type  Injury  
Event Description
Same case as mdr id: 2134265-2014-02766.(b)(4).It was reported that chest pain associated with diaphoresis, nonproductive cough, cardiogenic shock, myocardial infarction (mi) and in-stent thrombosis occurred.In (b)(6) 2010, the patient was diagnosed with q- wave st-elevation myocardial infarction (stemi) and cardiac catheterization was recommended.The index procedure was performed.Target lesion #1 was a de novo lesion located in proximal right coronary artery (rca) with 90% stenosis and was 20 mm long with a reference vessel diameter of 3.5 mm.The lesion was treated with direct stent placement using 3.50 x 28 mm taxus liberté stent, with 0% residual stenosis.Following stent in proximal rca, a grade ¿a¿ dissection was noted at the distal segment of stent and was treated with placement of a 3.00 x 12 mm taxus liberté bailout stent in an overlapping manner.Two days post-procedure, the patient was discharged on aspirin and prasugrel.In april 2014, the patient presented due to chest pain associated with diaphoresis and unproductive cough.Electrocardiogram (ecg) revealed second degree av block, right bundle branch block (rbbb) and possible inferior infarct.Cardiac enzymes were found to be elevated.Q-wave mi and cardiogenic shock occurred.At the time of event, the patient was taking aspirin only and the study drug was last taken in november 2012.Coronary angiography was performed and revealed 100% in-stent thrombosis.The patient was referred for percutaneous coronary intervention.An attempt was made to treat the occluded proximal rca extending to mid rca however, failed due to inability of the interventional wire to cross the lesion.The procedure was aborted.Ttp and an intraaortic balloon pump (iabp) were placed due to hemodynamic instability.The patient was treated medically and with hydration.Two days from procedure, the events were considered to be resolved without residual effects and the patient was discharged on aspirin and clopidogrel.
 
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TAXUS® LIBERTÉ®
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
ballybrit business park
galway
Manufacturer Contact
ingrid matte
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key3825299
MDR Text Key4398808
Report Number2134265-2014-02769
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P060008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/25/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/21/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/01/2011
Device Model NumberH7493893612300
Device Catalogue Number38936-1230
Device Lot Number0013003633
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/25/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/14/2009
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age41 YR
-
-